FDA Import Refusal 799-0355453-6/10003/1 — SANDOZ CANADA INCORPORATED
The FDA refused shipment 799-0355453-6/10003/1 from SANDOZ CANADA INCORPORATED (Canada) on January 2, 2026. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 2, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61LCY44 APIXABAN (ANTI-COAGULANT)
- Charges
- 75